ABCC7 p.Lys696Arg
ClinVar: |
c.2087A>G
,
p.Lys696Arg
?
, not provided
|
Predicted by SNAP2: | A: N (57%), C: D (59%), D: D (59%), E: N (57%), F: D (66%), G: D (71%), H: N (53%), I: D (59%), L: D (59%), M: D (53%), N: N (72%), P: D (71%), Q: D (59%), R: N (87%), S: D (63%), T: N (66%), V: D (59%), W: D (71%), Y: D (63%), |
Predicted by PROVEAN: | A: N, C: D, D: N, E: N, F: D, G: N, H: N, I: D, L: D, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: D, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Orphan missense mutations in the cystic fibrosis t... J Mol Diagn. 2011 Sep;13(5):520-7. Epub 2011 Jun 25. Fresquet F, Clement R, Norez C, Sterlin A, Melin P, Becq F, Kitzis A, Thoreau V, Bilan F
Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator a three-step biological approach to establishing a correlation between genotype and phenotype.
J Mol Diagn. 2011 Sep;13(5):520-7. Epub 2011 Jun 25., [PMID:21708286]
Abstract [show]
More than 1860 mutations have been found within the human cystic fibrosis transmembrane conductance regulator (CFTR) gene sequence. These mutations can be classified according to their degree of severity in CF disease. Although the most common mutations are well characterized, few data are available for rare mutations. Thus, genetic counseling is particularly difficult when fetuses or patients with CF present these orphan variations. We describe a three-step in vitro assay that can evaluate rare missense CFTR mutation consequences to establish a correlation between genotype and phenotype. By using a green fluorescent protein-tagged CFTR construct, we expressed mutated proteins in COS-7 cells. CFTR trafficking was visualized by confocal microscopy, and the cellular localization of CFTR was determined using intracellular markers. We studied the CFTR maturation process using Western blot analysis and evaluated CFTR channel activity by automated iodide efflux assays. Of six rare mutations that we studied, five have been isolated in our laboratory. The cellular and functional impact that we observed in each case was compared with the clinical data concerning the patients in whom we encountered these mutations. In conclusion, we propose that performing this type of analysis for orphan CFTR missense mutations can improve CF genetic counseling.
Comments [show]
None has been submitted yet.
No. Sentence Comment
61 The genotype was as follows: p.[Lys696Arg] (K696R).
X
ABCC7 p.Lys696Arg 21708286:61:32
status: NEWX
ABCC7 p.Lys696Arg 21708286:61:44
status: NEW97 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= CFTR Missense Mutation Biological Assay 3 JMD Month 2011, Vol. xx, No.
X
ABCC7 p.Lys696Arg 21708286:97:295
status: NEW109 Mixed Phenotype with P574S CFTR Variant The missense substitution p.[Pro574Ser] (P574S) lies within nucleotide-binding domain 1.
X
ABCC7 p.Lys696Arg 21708286:109:32
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:84
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:152
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:206
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:260
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:289
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:331
status: NEW119 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, K696R and p.[Pro841Arg] (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Lys696Arg 21708286:119:22
status: NEWX
ABCC7 p.Lys696Arg 21708286:119:75
status: NEW123 [1210-12T(7)] ϩ [1210-12T(7)] CBAVD ϩ Ø Ø 5/F/37 p.[Lys696Arg] Asymptomatic (prenatal CF diagnostics) ϩ Ø Ø 6/M/33 c.
X
ABCC7 p.Lys696Arg 21708286:123:74
status: NEW133 After using Western blot analysis (Figure 3B), the proportions of core-glycosylated protein for K696R and P841R appear insignificantly different from that of WT-CFTR (n ϭ 3, data not shown).
X
ABCC7 p.Lys696Arg 21708286:133:96
status: NEW134 Moreover, we observe by iodide efflux experiments that both mutations have similar functional consequence on CFTR activity: the maximum activation is reduced to 49.67% Ϯ 2.61% (n ϭ 4) for K696R and to 45.10% Ϯ 4.94% (n ϭ 4) for P841R (Figure 3C).
X
ABCC7 p.Lys696Arg 21708286:134:200
status: NEW161 B A calreticulin egremS475P calreticulin egremS475P WT F508del P574S CFTR C WT F508del P574S CFTR C B CFTR NaKATPase B CFTR NaKATPase C WT P574S *** WT P574S ***** 00 WT P574S 0 00 00 00 00 **** 00 WT P574S 0 00 00 00 00 0 50 100 WT % of maximal activation 0 50 100 WT % of maximal activationB/(B+C) (%) 100 0 200 300 400 500 B/(B+C) (%) 100 0 200 300 400 500 Figure 2.
X
ABCC7 p.Lys696Arg 21708286:161:96
status: NEW162 P574S amino acid substitution decreases CFTR protein maturation.
X
ABCC7 p.Lys696Arg 21708286:162:200
status: NEW192 One possible explanation could be that iodide effluxes are not sensitive enough to precisely evaluate the CFTR chloride channel activation process; notably, CFTR channel open probability could not be studied directly by this A B C P841R actin merge +TO-PRO K696R actin merge +TO-PRO P841R actin merge +TO-PRO K696R actin merge +TO-PRO % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R WT F508del P841R K696R B CFTR NaKATPase C WT F508del P841R K696R B CFTR NaKATPase C Figure 3.
X
ABCC7 p.Lys696Arg 21708286:192:257
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:309
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:377
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:431
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:485
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:514
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:556
status: NEW193 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Lys696Arg 21708286:193:0
status: NEW207 Obviously, patch-clamp analysis would be useful to measure the real impact of P574S in CFTR channel gating.
X
ABCC7 p.Lys696Arg 21708286:207:12
status: NEW209 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Lys696Arg 21708286:209:45
status: NEW211 The variant K696R was isolated from a familial study, in which we did not find any other CFTR mutation.
X
ABCC7 p.Lys696Arg 21708286:211:12
status: NEW60 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= was presented.
X
ABCC7 p.Lys696Arg 21708286:60:295
status: NEW62 The genotype was as follows: p.Lys696Arg (K696R).
X
ABCC7 p.Lys696Arg 21708286:62:31
status: NEWX
ABCC7 p.Lys696Arg 21708286:62:42
status: NEW82 [1210-12T(7)] ϩ [1210-12T(7)] CBAVD ϩ Ø Ø 5/F/37 p.[Lys696Arg] Asymptomatic (prenatal CF diagnostics) ϩ Ø Ø 6/M/33 c.
X
ABCC7 p.Lys696Arg 21708286:82:74
status: NEW110 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Lys696Arg 21708286:110:0
status: NEW158 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, p.Lys696Arg (K696R) and p.Pro841Arg (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Lys696Arg 21708286:158:22
status: NEWX
ABCC7 p.Lys696Arg 21708286:158:77
status: NEWX
ABCC7 p.Lys696Arg 21708286:158:88
status: NEW205 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Lys696Arg 21708286:205:45
status: NEW